Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

HIMS Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors ...

On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed ...

Hims & Hers Health ($HIMS) is one of the market’s most hotly debated stocks. The telehealth platform is shaking up ...

Current health news covers Novo Nordisk's ongoing lawsuits over Wegovy copies, influencer Michelle Miller's push for GMOs, IO Biotech's narrowly missed cancer vaccine goal, and China's ban on Spanish ...

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and ...

WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

For men, the key hormone testosterone triggers the development of the male reproductive organs during fetal development, ...

This week in health news, activist investor Engine Capital urges Avantor's board overhaul, China's Ab&B Bio-Tech IPO sees ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...